Studying the effect of platelet-rich plasma (PRP) and intralipid therapies on pregnancy outcomes in patients with recurrent implantation failure

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240515061807N1

Enrollment

240

Registered

2025-01-28

Start date

2025-01-24

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Intervention group: PRP is prepared from autologous blood using a two-step process. Approximately 8.5 mL of peripheral venous blood is drawn into a syringe containing 1.5 mL of anticoa

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: A history of two (or more) implantation failures Has frozen embryos

Exclusion criteria

Exclusion criteria: Severe oligospermia Endometriosis

Design outcomes

Primary

Measure	Time frame
Live birth. Timepoint: 9 months after intervention. Method of measurement: Examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNovin Daemi

Islamic Azad University

novin.daemi@yahoo.com+98 21 2660 2642

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026